Arbuckle Stuart A sold VRTX
February 26, 2024 · Form 4 insider transaction
Arbuckle Stuart A sold 5,034 shares of Vertex Pharmaceuticals Incorporated at $425.70 per share, a transaction worth $2.14M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
5,034
Price
$425.70
Total value
$2.14M
InsiderArbuckle Stuart A
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 26, 2024
Filing dateFebruary 27, 2024
Shares owned after49,691
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1, which was entered into on 02/28/2023.